Midwest Clinical Research LLC

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• COPD3 trials
• Asthma1 trial

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Genentech, Inc.1 trial
• Hoffmann-La Roche1 trial
• Janssen Research & Development, LLC1 trial
• Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1 trial

Running trials

• Recruiting

  A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

  NCT07746687· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

  NCT05878769· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting

Closed trials

• Completed

  Clinical Study of Ensifentrine-Glycopyrrolate (MK-5884A/RPL554) Fixed-dose Combination Dose Ranging in Participants With COPD (MK-5884A-029/RPL554-CO-212)

  NCT07016412· Phase 2· Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05037929· Phase 2· Genentech, Inc.· Source